Skip to Main Content

Author Details

Fubo Wang
Center for Genomic and Personalized Medicine, Guangxi Medical University
2011
67
22
PMIDPaper TitleJournal TitlePublished Year
37468393Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy.Eur Urol Oncol2024
36323640Long noncoding RNA as a potential diagnostic tool for prostate cancer: a systematic review and meta-analysis.Biomarkers2023
37488510Artificial intelligence for the diagnosis of clinically significant prostate cancer based on multimodal data: a multicenter study.BMC Med2023
36814419Establishment of a risk score model for bladder urothelial carcinoma based on energy metabolism-related genes and their relationships with immune infiltration.FEBS Open Bio2023
36759880Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer.J Exp Clin Cancer Res2023
36454163Urinary exosomal prostate-specific antigen is a noninvasive biomarker to detect prostate cancer: Not only old wine in new bottles.Int J Cancer2023
36059701Machine learning model for the prediction of prostate cancer in patients with low prostate-specific antigen levels: A multicenter retrospective analysis.Front Oncol2022
35795046Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy.Front Oncol2022
35785645Comparing pretreatment strategies to increase the yield and purity of human urinary extracellular vesicles.J Chromatogr B Analyt Technol Biomed Life Sci2022
36002886Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma.BMC Med2022
35972052Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy.Cancer Biol Med2022
33414463KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.Cell Death Dis2021
33785037Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer.Mol Cancer2021
34439239A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study.Cancers (Basel)2021
34659891Effect of <i>APOBEC3A</i> functional polymorphism on renal cell carcinoma is influenced by tumor necrosis factor-α and transcriptional repressor ETS1.Am J Cancer Res2021
34026644Serum Metabolic Profiling Identifies a Biomarker Panel for Improvement of Prostate Cancer Diagnosis.Front Oncol2021
33996477The application of virtual reality training for anastomosis during robot-assisted radical prostatectomy.Asian J Urol2021
33221996A novel miRNA inhibits metastasis of prostate cancer via decreasing CREBBP-mediated histone acetylation.J Cancer Res Clin Oncol2021
33420488Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression.Nat Cell Biol2021
33208562PSA density in the diagnosis of prostate cancer in the Chinese population: results from the Chinese Prostate Cancer Consortium.Asian J Androl2021
31107971The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.Int J Cancer2020
35117285Autonomic nerve regulation for prostate cancer: study based on the tissue transcriptional analysis.Transl Cancer Res2020
31952997A 13-gene risk score system and a nomogram survival model for predicting the prognosis of clear cell renal cell carcinoma.Urol Oncol2020
31857702Deubiquitinating enzyme USP33 restrains docetaxel-induced apoptosis via stabilising the phosphatase DUSP1 in prostate cancer.Cell Death Differ2020
33194612Long Non-Coding RNA SNHG1 Regulates the Wnt/β-Catenin and PI3K/AKT/mTOR Signaling Pathways <i>via</i> EZH2 to Affect the Proliferation, Apoptosis, and Autophagy of Prostate Cancer Cell.Front Oncol2020
32655718FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer.Dis Markers2020
32111915Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery.Sci Rep2020
32460179Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer.Eur J Cancer2020
32167077MAGI-2 downregulation: a potential predictor of tumor progression and early recurrence in Han Chinese patients with prostate cancer.Asian J Androl2020
32566661Differential Expression and Prognostic Value of Cytoplasmic and Nuclear Cyclin D1 in Prostate Cancer.Biomed Res Int2020
31210145Prevalence and clinical application of <i>TMPRSS2-ERG</i> fusion in Asian prostate cancer patients: a large-sample study in Chinese people and a systematic review.Asian J Androl2020
31292732Robotic enucleation of adrenal masses: technique and outcomes.World J Urol2020
31253384The margin strategy in laparoscopic partial nephrectomy with selective renal artery clamping: Anatomical basis, surgical technique and comparative outcomes.Asian J Surg2020
30972621Replicate systematic review and meta-analyses on robotic surgery: a quality appraisal and overlap investigation.Surg Endosc2020
30565487Navigation of Intelligent/Interactive Qualitative and Quantitative Analysis Three-Dimensional Reconstruction Technique in Laparoscopic or Robotic Assisted Partial Nephrectomy for Renal Hilar Tumors.J Endourol2019
31983129Over-expression of TM4SF1 improves cell metastasis and growth by activating ERK1/2 signaling pathway in human prostate cancer.J BUON2019
31793344Prostate Cancer Diagnosis Using Urine Sediment Analysis-Based α-Methylacyl-CoA Racemase Score: A Single-Center Experience.Cancer Control2019
31555390Heterogeneity of PTEN and PPAR-γ in cancer and their prognostic application to bladder cancer.Exp Ther Med2019
31534967Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for Prostate Cancer in Chinese Population.Biomed Res Int2019
30809318Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP?Dis Markers2019
30693666The preoperative neutrophil-to-lymphocyte ratio is not a marker of prostate cancer characteristics but is an independent predictor of biochemical recurrence in patients receiving radical prostatectomy.Cancer Med2019
28970251Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice.FASEB J2018
30036616Direct Lateral Access to Renal Artery During Transperitoneal Laparoscopic Partial Nephrectomy: Surgical Technique and Comparative Outcomes.Urology2018
29441565Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer.Int J Cancer2018
26780868Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy.Asian J Androl2017
28292438MAOA-Dependent Activation of Shh-IL6-RANKL Signaling Network Promotes Prostate Cancer Metastasis by Engaging Tumor-Stromal Cell Interactions.Cancer Cell2017
26865432Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer.Sci Rep2016
26545398Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.Mol Cell Proteomics2016
27185342Development and external multicenter validation of Chinese Prostate Cancer Consortium prostate cancer risk calculator for initial prostate biopsy.Urol Oncol2016
26808578A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.Cancer Lett2016
  • 1 - 50 of 67

Recommended Authors

Jiayu Liang
institute of urology
Career Start Year 2016
Number of shared co-authors 1
Yaser Gamallat
Cumming School of Medicine, University of Calgary
Career Start Year 2016
Number of shared co-authors 1
Yuliang Wang
The Chinese University of Hong Kong
Career Start Year 2014
Number of shared co-authors 0
Travis Gerke
The Prostate Cancer Clinical Trials Consortium
Career Start Year 2014
Number of shared co-authors 0
Simpa S Salami
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 3
Irene Casanova-Salas
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
Career Start Year 2012
Number of shared co-authors 2
Yusuke Goto
Chiba University Graduate School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 3
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 4
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 0
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 8
Chang Wook Jeong
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 3
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 7
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 5
Lin Qi
Xiangya Hospital of Central South University
Career Start Year 2003
Number of shared co-authors 0
Ashley E Ross
Northwestern University
Career Start Year 2003
Number of shared co-authors 5
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Seok Soo Byun
Seoul National University Bundang Hospital
Career Start Year 2002
Number of shared co-authors 0
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 8
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 3
Seok-Soo Byun
Seoul National University Bundang Hospital
Career Start Year 2002
Number of shared co-authors 0
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2000
Number of shared co-authors 0
Yuzhuo Wang
University of British Columbia
Career Start Year 2000
Number of shared co-authors 10
Hyun Moo Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 5
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Byung Ha Chung
Yonsei University College of Medicine and Gangnam Severance Hospital
Career Start Year 1992
Number of shared co-authors 0
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 6
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 8

Collaborators

Shancheng Ren
Shanghai Changzheng Hospital
Co-authored papers 23
Yasheng Zhu
Changhai Hospital, Naval Military Medical University
Co-authored papers 12
Yongwei Yu
Changhai Hospital
Co-authored papers 7
Jiaoti Huang
Duke University School of Medicine
Co-authored papers 3
Yue Yang
Institute of Cancer Prevention and Treatment, Harbin Medical University
Co-authored papers 3
Fei Liu
Shanghai Changhai Hospital
Co-authored papers 2
Zhengping Zhuang
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Ranjan J Perera
Co-authored papers 1
Javier Mariscal
Samuel Oschin Comprehensive Cancer Institute
Co-authored papers 1
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Song Wu
The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group)
Co-authored papers 1
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 1
Na Zhang
Obstetrics and Gynecology Hospital of Fudan University
Co-authored papers 1
Bo Zhang
Novel Bioinformatics Co.
Co-authored papers 1
Riccardo Campi
Careggi University Hospital
Co-authored papers 1
Weidong Chen
Novel Bioinformatics Co.
Co-authored papers 1
Dai Chen
University of Washington
Co-authored papers 1
Gary P Schroth
Co-authored papers 1
Huanming Yang
Experimental Research Center, China Academy of Chinese Medical Sciences
Co-authored papers 1
Jianhua Wang
Anhui University of Science & Technology
Co-authored papers 1
Zhengfang Yi
The Institute of Biomedical Sciences, East China Normal University
Co-authored papers 1
Helen Loo Yau
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Qinghua Guo
Novel Bioinformatics Co.
Co-authored papers 1
Zhou Jiang
China University of Geosciences
Co-authored papers 1
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 1
Jian Wang
Institute of Medical Research, Northwestern Polytechnical University
Co-authored papers 1
Daniel D De Carvalho
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 1
Yin Liu
Fudan University Shanghai Cancer Center
Co-authored papers 1
Release 1.2